Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOICE: Ultra-low Dose Estradiol/NETA for Menopausal Symptoms
NCT00184795Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- May 2004
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of estradiol, norethindrone acetate transdermal delivery system in vasomotor symptoms, sponsored by Novo Nordisk. Started May 2004; status: completed.
02
Drugs
estradiolnorethindrone acetate transdermal delivery system
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT00184795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00184795.